RGB-286638

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameRGB-286638
Drug Alias NameRGB-286638
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase inhibitors
TargetsCyclin-dependent kinase
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAgennix
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAgennix
Active IndicationsN/A
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A